TREATMENT STRATEGIES IN PATIENTS WITH ADVANCED EGFR MUTATION-POSITIVE NSCLC IN CENTRAL EUROPE: FINDINGS FROM THE INSIGHT OBSERVATIONAL STUDY

被引：0

作者：

Cufer, Tanja ^{[1
]}

Dziadziuszko, Rafal ^{[2
]}

Berzinec, Peter ^{[3
]}

Kowalczyk, Anna ^{[2
]}

Dusek, Ladislav ^{[4
]}

Popper, Helmut ^{[5
]}

Kern, Izidor ^{[6
]}

Olszewski, Wlodzimierz ^{[7
]}

Milanowski, Janus ^{[8
]}

Lohinai, Zoltan ^{[9
]}

Ramlau, Katarzyna ^{[10
]}

Chorostowska-Wynimko, Joanna ^{[11
]}

Tomiskova, Marcela ^{[12
]}

Kultan, Juraj ^{[12
]}

Pesek, Milos ^{[12
]}

Ramlau, Rodryg ^{[10
]}

Eisterer, Wolfgang ^{[13
]}

Medvecova, Lenka ^{[14
]}

Maciejewska-Izdebska, Alicia ^{[2
]}

Mazal, Juraj ^{[15
]}

Bajcic, Paolo ^{[16
]}

Kandrnal, Vit ^{[4
]}

Pirker, Robert ^{[17
]}

机构：

[1] Univ Clin Golnik, Med Oncol Unit, Golnik, Slovenia

[2] Med Univ Gdansk, Dept Radiotherapy & Oncol, Gdansk, Poland

[3] Specialised Hosp St Zoerardus Zobor, Dept Oncol, Nitra, Slovakia

[4] Masaryk Univ, Inst Biostat & Anal, CS-60177 Brno, Czech Republic

[5] Med Univ Graz, Dept Pathol, Graz, Austria

[6] Univ Clin Golnik, Lab Cytol & Pathol, Golnik, Slovenia

[7] Oncol Inst Maria Sklodowska Curie, Dept Pathol, Warsaw, Poland

[8] Med Univ, Dept Pneumol Oncol & Allergol, Gdansk, Poland

[9] Natl Koranyi Inst, Dept Pneumol, Budapest, Hungary

[10] Poznan Univ Med Sci, Dept Oncol, Poznan, Poland

[11] Natl Inst TB & Lung Dis, Lab Mol Diagnost & Immunol, Warsaw, Poland

[12] Univ Hosp, Dept Pulm Dis & TB, Olomouc, Czech Republic

[13] Med Univ Innsbruck, Dept Med, A-6020 Innsbruck, Austria

[14] Adus Healthcare Ctr, Dept Oncol, Bratislava, Slovakia

[15] Univ Hosp FD Roosevelt, Dept Pneumol, Bratislava, Slovakia

[16] Boehringer Ingelheim Rcv, Med Affairs Dept, Vienna, Austria

[17] Med Univ Vienna, Dept Med 1, Vienna, Austria

来源：

JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P2.11-019

引用

页码：S897 / S898

页数：2

共 50 条

[1] Observational study of rebiopsy in EGFR-TKI-resistant patients with EGFR mutation-positive advanced NSCLC
Kenichi Koyama
Satoru Miura
Satoshi Watanabe
Satoshi Shoji
Jun Koshio
Yoshiki Hayashi
Daisuke Ishikawa
Ko Sato
Takao Miyabayashi
Masaaki Okajima
Takeshi Ota
Tomohiro Tanaka
Naoya Matsumoto
Hideyuki Kuriyama
Tetsuya Abe
Koichiro Nozaki
Kosuke Ichikawa
Rie Kondo
Hiroshi Tanaka
Toshiaki Kikuchi
Scientific Reports, 12
[2] Observational study of rebiopsy in EGFR-TKI-resistant patients with EGFR mutation-positive advanced NSCLC
Koyama, Kenichi
Miura, Satoru
Watanabe, Satoshi
Shoji, Satoshi
Koshio, Jun
Hayashi, Yoshiki
Ishikawa, Daisuke
Sato, Ko
Miyabayashi, Takao
Okajima, Masaaki
Ota, Takeshi
Tanaka, Tomohiro
Matsumoto, Naoya
Kuriyama, Hideyuki
Abe, Tetsuya
Nozaki, Koichiro
Ichikawa, Kosuke
Kondo, Rie
Tanaka, Hiroshi
Kikuchi, Toshiaki
SCIENTIFIC REPORTS, 2022, 12 (01)
[3] EGFR MUTATIONS IN NSCLC PATIENTS IN CENTRAL EUROPE: THE INSIGHT OBSERVATIONAL STUDY
Pirker, Robert
Dziadziuszko, Rafal
Berzinec, Peter
Dusek, Ladislav
Cufer, Tanja
Bajcic, Paolo
Popper, Helmut
Olszewski, Wlodzimierz
Chorostowska-Wynimko, Joanna
Skrickova, Jana
Kolek, Vitezslav
Pesek, Milos
Ostoros, Gyula
Chmielewska, Izabela
Medvecova, Lenka
Eisterer, Wolfgang
Kandrnal, Vit
Mazal, Juraj
Popper, Helmuth
Olszewski, Wlodzimierz
Ramlau, Rodryg
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S897 - S897
[4] Osimertinib in EGFR Mutation-Positive Advanced NSCLC
不详
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (13): : 1260 - 1261
[5] Afatinib for the treatment of EGFR mutation-positive NSCLC: A review of clinical findings
Harvey, R. Donald
Adams, Val R.
Beardslee, Tyler
Medina, Patrick
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (06) : 1461 - 1474
[6] Cardiac Safety Assessment of Lazertinib: Findings From Patients With EGFR Mutation-Positive Advanced NSCLC and Preclinical Studies
Jang, Seong Bok
Kim, Kyeong Bae
Sim, Sujin
Cho, Byoung Chul
Ahn, Myung-Ju
Han, Ji-Youn
Kim, Sang -We
Lee, Ki Hyeong
Cho, Eun Kyung
Haddish-Berhane, Nahor
Mehta, Jaydeep
Oh, Se-Woong
JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (10):
[7] EGFR MUTATION TESTING METHODS IN CLINICAL PRACTICE IN CENTRAL EUROPE: FINDINGS FROM THE INSIGHT OBSERVATIONAL STUDY
Olszewski, Wlodzimierz
Popper, Helmut
Kern, Izidor
Muellauer, Leonhard
Dziadziuszko, Rafal
Berzinec, Peter
Dusek, Ladislav
Cufer, Tanja
Bajcic, Paolo
Bortlicek, Zbynek
Copakova, Lucia
Dome, Balazs
Chorostowska-Wynimko, Joanna
Robesova, Blanka
Kolek, Vitezslav
Pesek, Milos
Ramlau, Rodryg
Eisterer, Wolfgang
Medvecova, Lenka
Krawczyk, Pawel
Mazal, Juraj
Pirker, Robert
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1252 - S1252
[8] Sequential treatment with afatinib and osimertinib in real-world patients with EGFR mutation-positive advanced NSCLC: the GioTag study
Hochmair, M.
Cufer, T.
Morabito, A.
Hao, D.
Yang, C. Ta
Soo, R.
Yang, J.
Gucalp, R.
Halmos, B.
Wang, L.
Golembesky, A.
Maerten, A.
O'Byrne, K.
LUNG CANCER, 2019, 127 : S59 - S60
[9] Sequential treatment with afatinib and osimertinib in real-world patients with EGFR mutation-positive advanced NSCLC: the GioTag study
Hochmair, M.
Cufer, T.
Morabito, A.
Hao, D.
Yang, C.
Soo, R.
Yang, J. C.
Gucalp, R. Rasim
Halmos, B.
Wang, L.
Golembesky, A.
Maerten, A.
O'Byrne, K.
LUNG CANCER, 2019, 127 : S37 - S37
[10] Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLC
Yvette N. Lamb
Targeted Oncology, 2021, 16 : 687 - 695

← 1 2 3 4 5 →